NASDAQ Companies

CARMEL, Ind., Dec. 18, 2024 (GLOBE NEWSWIRE) — MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the […]

SOUTH SAN FRANCISCO, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc. (“ALX Oncology” or “the Company”) (Nasdaq: […]

SOUTH SAN FRANCISCO, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) — Septerna, a clinical-stage biotechnology company pioneering a new era of […]

Dravet syndrome is a genetic developmental and epileptic encephalopathy (DEE) often caused by a mutation in SCN1A This is the […]

ZyVersa is advancing a pipeline of first-in-class drug candidates built around two proprietary technologies. – Inflammasome ASC Inhibitor IC 100 […]

Key preclinical milestone for novel, non-opioid extended-release pain therapeutic   SARASOTA, FL, Dec. 18, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. […]

QUEBEC CITY, Canada, Dec. 18, 2024 (GLOBE NEWSWIRE) — LeddarTech® Holdings Inc. (“LeddarTech”) (Nasdaq: LDTC), an automotive software company that […]

DETROIT, Dec. 18, 2024 (GLOBE NEWSWIRE) — Amesite Inc. (NASDAQ: AMST), creator of the NurseMagic™ app, has closed on contracts […]

NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory […]

CHANDLER, Ariz., Dec. 18, 2024 (GLOBE NEWSWIRE) — Turnkey touch controllers are a fast and easy way to upgrade from […]